Avantra Biosciences offers the Q400 Biomarker Workstation and Angio Qx BioChip Immunoassay, a system that provides quantitative protein biomarker results for 10 analytes in less than an hour with less than five minutes for sample preparation. Multiplex protein assays can be helpful in evaluating the association between elevated protein levels, patient phenotype and drug response.
The Angio Qx Immunoassay is a member of the Avantra QPDx biomarker detection product line for use with the Q400 Biomarker Workstation. The platform consists of a self-contained immunoassay BioChip and instrument, for use in the automated measurement of key biomarkers.
The QPDx platform offers users a rapid, easy-to-use, high quality bench top quantitative multiplex protein assay platform with extremely low CVs and very little setup time, according to the company.
